Case Study Pharmaceutical



2020 saw a drop in Japan entry clients as companies took a more cautious approach to the market. 2021 and 2022 have seen this bounce back with more enquiries than usual as businesses strive to capitalize on the strong economic conditions and expand into Asian markets directly.

Titan Healthcare has already cemented itself as the Japan start-up expert for Japan and recent successes have furthered that. With several country managers successfully on-boarded we have managed to support clients across pharmaceuticals, medical devices, diagnostics, and technology to start up their operations here.

Titan is actively expanding our leadership network to help strengthen our clients and continue to support businesses establishing a presence in Japan. 


More Posts

Empowering Medical Affairs Autonomy

In the dynamic landscape of pharmaceutical and healthcare industries, the relationship between the Medical Affairs function and commercial organizations is undergoing a significant transformation. The

Send Us A Message